Rocket Lab: The Market Is Still Wrong About It

Rocket Lab is rated Buy with 24% upside potential, supported by a planned Q4 2026 Neutron launch, the Iridium Communications acquisition, and backlog growth that improves revenue visibility. Q2 2026 revenue rose 62% year over year, margins improved, and liquidity increased to $2.4 billion, strengthening the company's capacity to execute its growth plan. The bullish thesis argues these catalysts outweigh pressure from the recent share-price sell-off.

Analysis

RKLB is transitioning from a launch-services multiple toward a vertically integrated space-infrastructure valuation, but the re-rating depends on proving that Neutron can become a repeatable, positive-gross-margin program rather than another capital-intensive development cycle. The key second-order benefit of adding Iridium’s contracted service revenues is lower revenue volatility and a potentially cheaper cost of capital; the key offset is that satellite-network cash flows may be used to subsidize launch development, obscuring standalone Neutron economics. SpaceX remains the principal competitive constraint: any further reduction in rideshare pricing or Starship deployment progress would pressure RKLB’s addressable launch and satellite-bus margins.

Over the next 1-3 months, execution milestones—engine qualification, pad readiness, customer deposits, and disclosed launch cadence—matter more than quarterly revenue beats. A schedule slip of even one or two quarters would likely compress the premium growth multiple because it extends peak cash burn and delays the evidence needed to underwrite capacity utilization. The liquidity position reduces near-term financing risk, but does not eliminate dilution risk if Neutron’s development budget rises materially above current expectations.

The consensus may be underestimating the strategic value of owning both spacecraft production and assured launch access for defense customers, where mission assurance and domestic supply-chain control can matter more than lowest-price launch. Conversely, the bullish framing may overstate acquisition synergies until management discloses integration costs, retained Iridium capex needs, financing terms, and whether the acquired cash flow is contractually durable through satellite-replacement cycles. This is a catalyst-driven long, not a clean valuation trade, until Neutron schedule confidence is independently validated.

Key Decisions for Investors

• Initiate a starter long RKLB only on confirmation of Neutron engine/pad milestones or a pullback tied to broad risk-off conditions rather than schedule deterioration; size for a 12-18 month horizon. Target a 25-40% upside if first-launch timing holds and contracted backlog converts, with thesis invalidation on a material launch-delay disclosure, incremental equity raise, or materially higher Neutron capex guidance.
• Express relative confidence through long RKLB / short IRDM only after acquisition terms are fully disclosed and if the implied IRDM purchase multiple exceeds the value of contracted cash flows. The pair isolates RKLB’s integration and platform-synergy upside, but should be avoided if the consideration is heavily stock-funded or IRDM receives a takeover bid premium that cannot be hedged efficiently.
• Do not add aggressively ahead of the first Neutron launch; use post-launch confirmation as the higher-probability entry if initial flight data validates vehicle performance. A successful launch without a credible cadence and customer-manifest update is insufficient—watch for evidence that fixed launch infrastructure can be absorbed across multiple annual missions.
• Set an event alert for SpaceX pricing changes, Starship operational milestones, and U.S. defense procurement awards. New low-cost heavy-lift capacity is the principal multiple-compression risk for RKLB, while a meaningful defense award or multi-launch commitment would improve utilization visibility and justify adding exposure.